Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PINK vs QAAGZX overlap: 41% of top holdings shared

Bottom line

How much do PINK and QAAGZX overlap?

41% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 40.1% of PINK's assets and 46.0% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.

QAAGZX holds far more positions (277 vs 54), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PINKQAAGZX
Weight overlap (top 25)41%
Shared holdings12
Weight in shared holdings40.1%46.0%
Total positions54277
Expense ratio0.51%0.86%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings PINK and QAAGZX have in common

Holding% of PINK% of QAAGZXOverlap
Eli Lilly & Company LLY5.91%14.06%5.91%
Unitedhealth Group Inc UNH5.76%5.88%5.76%
Johnson & Johnson JNJ5.45%6.64%5.45%
Abbvie Inc ABBV4.52%5.12%4.52%
Thermo Fisher Scientific Inc TMO3.23%2.53%2.53%
Gilead Sciences Inc GILD2.87%2.79%2.79%
Elevance Health Inc ELV2.73%1.54%1.54%
Danaher Corp DHR2.28%1.44%1.44%
Amgen Inc AMGN2.12%1.80%1.80%
Cvs Health Corp CVS2.01%0.93%0.93%
Cardinal Health Inc CAH1.78%1.04%1.04%
Vertex Pharmaceuticals Inc VRTX1.45%2.26%1.45%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PINK

  1. Purecycle Technologies Inc — 6.89%
  2. United Therapeutics Corp — 6.86%
  3. Novo Nordisk A/s — 6.75%
  4. Warby Parker Inc — 5.46%
  5. Jazz Pharmaceuticals Plc — 4.61%
  6. Biohaven Ltd — 4.32%
  7. Benitec Biopharma Inc — 3.75%
  8. Align Technology Inc — 3.14%
  9. 10x Genomics Inc — 3.13%
  10. Quest Diagnostics Inc — 2.94%
  11. Astrazeneca Plc — 1.81%
  12. Establishment Labs Holdings Inc — 1.45%
  13. Eyepoint Inc — 1.44%

Only in QAAGZX

  1. Merck & Co. Inc. — 4.00%
  2. Bristol-myers Squibb Co — 2.12%
  3. Abbott Laboratories — 1.91%
  4. Intuitive Surgical Inc — 1.89%
  5. Stryker Corp — 1.78%
  6. Natera Inc — 1.44%
  7. Guardant Health Inc — 1.22%
  8. Royalty Pharma Plc- Cl A — 0.97%
  9. Tenet Healthcare Corp — 0.94%
  10. Kymera Therapeutics Inc — 0.89%
  11. T. Rowe Price Government Reserve Fund — 0.87%
  12. Protagonist Therapeutics Inc — 0.85%
  13. Moderna Therapeutics Inc — 0.83%

Asset mix

Asset typePINKQAAGZX
Stocks99.6%96.9%
Preferred stock—2.2%
Cash & short-term funds0.4%0.9%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryPINKQAAGZX
US81.0%92.3%
DK6.8%0.7%
VG5.8%—
IE4.7%0.8%
GB1.8%1.8%
NL—1.0%
BM—0.7%
CA—0.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do PINK and QAAGZX overlap?
About 41% by weight. 12 securities appear in both funds' top 25 holdings; they make up 40.1% of PINK's assets and 46.0% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PINK and QAAGZX have in common?
The largest shared holdings are Eli Lilly & Company, Unitedhealth Group Inc, Johnson & Johnson, Abbvie Inc, Gilead Sciences Inc.
Should I own both PINK and QAAGZX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PINK or QAAGZX?
QAAGZX is broader, with 277 positions versus 54 for PINK. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.